posted on 2024-09-19, 15:06authored byTimothy
F. Czajka, David J. Vance, Renji Song, Nicholas J. Mantis
Expression of camelid-derived, single-domain antibodies
(VHHs) within the cytoplasm of mammalian cells as “intrabodies”
has opened up novel avenues for medical countermeasures against fast-acting
biothreat agents. In this report, we describe a heterodimeric intrabody
that renders Vero cells virtually impervious to ricin toxin (RT),
a potent Category B ribosome-inactivating protein. The intrabody consists
of two structurally defined VHHs that target distinct epitopes
on RT’s enzymatic subunit (RTA): V9E1 targets RTA’s
P-stalk recruitment site, and V2A11 targets RTA’s active site.
Resistance to RT conferred by the biparatopic VHH construct
far exceeded that of either of the VHHs alone and effectively
inhibited all measurable RT-induced cytotoxicity in vitro. We propose that the targeted delivery of bispecific intrabodies
to lung tissues may represent a novel means to shield the airways
from the effects of inhalational RT exposure.